Clear selection
Switching the pharmaceutical dosage form of extended-release valproate is associated with therapeutic modification of antiepileptic therapy

28th ICPE - International Conference on Pharmacoepidemiology and Therapeutic Risk Assessment, 23. - 26. August 2012, Barcelona, Spain: Pharmacoepi and Drug Safety 2012 Vol. 21 Suppl. 3 S. 242 (Abstract Nummer 516).

Conflicts of interests: Stephanie von Klot is currently employed by Boehringer Ingelheim GmbH. Boehringer Ingelheim GmbH did not contribute any direct or indirect financing to this study.